Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AmerisourceBergen has signed a definitive agreement to sell its Canadian pharmaceutical distribution business, AmerisourceBergen Canada (ABCC), to Canadian-owned national full-line distributor Kohl & Frisch.
Subscribe to our email newsletter
The estimated sale price is expected to be between $80m and $100m, of which approximately half will be financed by AmerisourceBergen.
ABCC represents approximately 2% of AmerisourceBergen’s total revenues.
AmerisourceBergen, however, will retain its Canadian specialty business.
The transaction, which is subject to customary closing conditions, is likely to close in the third quarter of fiscal 2013.